Latest / Community Health Media
Dr. Hope Rugo & Dr. Rebecca Shatsky - Dato-DXd & First-Line ADC Strategies in Metastatic TNBC
How is Dato-DXd redefining first-line mTNBC? In this episode of CHM Conversations, Dr. Hope Rugo and Dr. Rebecca Shatsky discuss the TROPION-Breast02 trial results and how this data fits into the broader landscape alongside the ASCENT-03 findings.
The clinicians focus on the shift toward frontline Trop2-directed strategies and how these agents are challenging the chemotherapy-only paradigm. They also address the practicalities of management—specifically managing stomatitis and ocular toxicity while navigating CNS disease and supportive care.
An essential resource for oncology clinicians…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.